1. Home
  2. CBL vs EMBC Comparison

CBL vs EMBC Comparison

Compare CBL & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • EMBC
  • Stock Information
  • Founded
  • CBL 1978
  • EMBC 1924
  • Country
  • CBL United States
  • EMBC United States
  • Employees
  • CBL N/A
  • EMBC N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • EMBC Medical/Dental Instruments
  • Sector
  • CBL Real Estate
  • EMBC Health Care
  • Exchange
  • CBL Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • CBL 777.7M
  • EMBC 726.8M
  • IPO Year
  • CBL 1993
  • EMBC N/A
  • Fundamental
  • Price
  • CBL $27.37
  • EMBC $11.73
  • Analyst Decision
  • CBL
  • EMBC Buy
  • Analyst Count
  • CBL 0
  • EMBC 2
  • Target Price
  • CBL N/A
  • EMBC $19.00
  • AVG Volume (30 Days)
  • CBL 149.8K
  • EMBC 597.5K
  • Earning Date
  • CBL 08-08-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • CBL 5.85%
  • EMBC 5.12%
  • EPS Growth
  • CBL 2069.88
  • EMBC N/A
  • EPS
  • CBL 2.16
  • EMBC 0.89
  • Revenue
  • CBL $528,212,000.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • CBL N/A
  • EMBC N/A
  • Revenue Next Year
  • CBL N/A
  • EMBC N/A
  • P/E Ratio
  • CBL $12.66
  • EMBC $13.15
  • Revenue Growth
  • CBL 0.03
  • EMBC N/A
  • 52 Week Low
  • CBL $21.10
  • EMBC $9.20
  • 52 Week High
  • CBL $33.54
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • CBL 62.61
  • EMBC 64.56
  • Support Level
  • CBL $26.00
  • EMBC $9.68
  • Resistance Level
  • CBL $27.86
  • EMBC $11.73
  • Average True Range (ATR)
  • CBL 0.53
  • EMBC 0.49
  • MACD
  • CBL 0.11
  • EMBC 0.21
  • Stochastic Oscillator
  • CBL 78.95
  • EMBC 98.49

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: